BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

R. D. Hofheinz, C. Porta, G. Hartung, A. Santoro, A. R. Hanauske, K. Kutz, A. Stern, P. Barbieri, E. Verdi, R. Hehlmann, A. Hochhaus

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)'. Together they form a unique fingerprint.

Medicine & Life Sciences